This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Kirin Biomaterials Co., Ltd., Otsuka Pharmaceutical Factory, Inc., Rensselaer Polytechnic Institute. Active years: 2025.
Company Filing History:
1 out of 1 
1 out of 192 
1 out of 647 
Years Active: 2025
Title: Aki Nishibara: Innovator in Sulfated Polysaccharide Production
Introduction
Aki Nishibara is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of biochemistry, particularly in the production of sulfated polysaccharides. His innovative methods have the potential to impact various industries, including pharmaceuticals and biotechnology.
Latest Patents
Aki Nishibara holds a patent for a "Method for producing sulfated polysaccharide and method for producing PAPS." This invention provides a method for producing sulfated polysaccharides by utilizing a PAPS production/regeneration system that leverages the metabolic activity of microorganisms. The process involves mixing inexpensive raw materials, such as magnesium sulfate, with a microorganism expressing a sulfation enzyme. Additionally, the invention outlines a method for producing PAPS from affordable raw materials, which includes preparing a transformant of a bacterium that contains specific genes and conducting reactions using a reaction solution containing ATP or an ATP source.
Career Highlights
Throughout his career, Aki Nishibara has worked with esteemed organizations, including Rensselaer Polytechnic Institute and Otsuka Pharmaceutical Factory, Inc. His experience in these institutions has allowed him to refine his research and contribute to advancements in his field.
Collaborations
Aki has collaborated with notable colleagues, including Ryosuke Kato and Shin-ichi Hashimoto. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Aki Nishibara's work in the production of sulfated polysaccharides showcases his innovative spirit and dedication to advancing biochemistry. His contributions are likely to have lasting effects on the industry and inspire future research.